Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
about
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Neuroblastoma Patients' KIR an ...... the Children's Oncology Group.
@en
Neuroblastoma Patients' KIR an ...... the Children's Oncology Group.
@nl
type
label
Neuroblastoma Patients' KIR an ...... the Children's Oncology Group.
@en
Neuroblastoma Patients' KIR an ...... the Children's Oncology Group.
@nl
prefLabel
Neuroblastoma Patients' KIR an ...... the Children's Oncology Group.
@en
Neuroblastoma Patients' KIR an ...... the Children's Oncology Group.
@nl
P2093
P2860
P1476
Neuroblastoma Patients' KIR an ...... the Children's Oncology Group.
@en
P2093
Amy K Erbe
Andrew L Gilman
Arlene Naranjo
Dustin Hess
Eneida A Mendonça
Jacquelyn A Hank
John M Maris
Julie R Park
Katherine K Matthay
KyungMann Kim
P2860
P304
P356
10.1158/1078-0432.CCR-17-1767
P407
P577
2017-10-02T00:00:00Z